Skip to main content

Table 2 Effects of various variables on anthracycline-induced subclinical cardiotoxicity in DLBCL patients completed 3 cycles chemotherapy

From: Study on influencing factors of anthracycline-induced subclinical cardiotoxicity in DLBCL patients administered (R)-CHOP

Characteristics OR (95%CI) P-value
Age, per 1 year 1.000 (0.964, 1.036) 0.982
Male, yes versus no 0.833 (0.316, 2.201) 0.713
BMI, per 1 kg/m2 1.219 (1.033,1.438) 0.019
Smoking, yes versus no 3.304 (1.067, 10.226) 0.038
GLS, per -1% 1.200 (0.949, 1.517) 0.129
E, per 1 cm/s 1.030 (0.991, 1.070) 0.138
e’, per 1 cm/s 1.258 (0.980, 1.614) 0.071
LDL-C, per 1 mmol/L 2.016 (0.992,4.095) 0.053
HDL-C, per 1 mmol/L 0.371 (0.082, 1.683) 0.199
NT-proBNP, per 1 ng/L 0.993 (0.986,1.000) 0.066
TG, per 1 mmol/L 1.806 (0.942,3.462) 0.075
  1. Bold values indicate statistical significance
  2. BMI Body mass index, cTnT cardiac troponin T, Cr Creatinine, FS Fractional shortening, GLS Global longitudinal peak systolic strain, HDL-C High-density lipoprotein cholesterol, LDL-C Low-density lipoprotein cholesterol, NT-proBNP N terminal-pro brain natriuretic peptide, TG Total cholesterol